Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (28)
Qian Huang, Maocuo Peng, Yiya Gu, Jixing Wu, Yuan Zhan, Zhesong Deng, Shanshan Chen, Ruonan Yang, Jinkun Chen & Jungang Xie. (2022) Metabolism-Related Gene TXNRD1 Regulates Inflammation and Oxidative Stress Induced by Cigarette Smoke through the Nrf2/HO-1 Pathway in the Small Airway Epithelium. Oxidative Medicine and Cellular Longevity 2022, pages 1-16.
Crossref
Crossref
Sana Daneshamouz, Ubong Eduok, Amira Abdelrasoul & Ahmed Shoker. (2021) Protein-bound uremic toxins (PBUTs) in chronic kidney disease (CKD) patients: Production pathway, challenges and recent advances in renal PBUTs clearance. NanoImpact 21, pages 100299.
Crossref
Crossref
Heyam Saad Ali, Babiker M. El-Haj, Salim Saifullah & Muhammad Kawish. 2020. Metal Nanoparticles for Drug Delivery and Diagnostic Applications. Metal Nanoparticles for Drug Delivery and Diagnostic Applications
43
58
.
H. Hirvonen, H. Kautiainen, E. Moilanen, M. Mikkelsson & M. Leirisalo-Repo. (2017) The effect of cryotherapy on total antioxidative capacity in patients with active seropositive rheumatoid arthritis. Rheumatology International 37:9, pages 1481-1487.
Crossref
Crossref
Lloyd R.A. James, Zhi-Qiang Xu, Ronald Sluyter, Emma L. Hawksworth, Celine Kelso, Barry Lai, David J. Paterson, Martin D. de Jonge, Nicholas E. Dixon, Jennifer L. Beck, Stephen F. Ralph & Carolyn T. Dillon. (2015) An investigation into the interactions of gold nanoparticles and anti-arthritic drugs with macrophages, and their reactivity towards thioredoxin reductase. Journal of Inorganic Biochemistry 142, pages 28-38.
Crossref
Crossref
Parvathy R. Chandran & Reny Thankam Thomas. 2015. Nanotechnology Applications for Tissue Engineering. Nanotechnology Applications for Tissue Engineering
221
237
.
Kristen K. Comfort, Elizabeth I. Maurer, Laura K. Braydich-Stolle & Saber M. Hussain. (2011) Interference of Silver, Gold, and Iron Oxide Nanoparticles on Epidermal Growth Factor Signal Transduction in Epithelial Cells. ACS Nano 5:12, pages 10000-10008.
Crossref
Crossref
Simon P. Fricker. 2009. PATAI'S Chemistry of Functional Groups. PATAI'S Chemistry of Functional Groups.
Concetta Crisafulli, Emanuela Mazzon, Carmelo Muia, PaoloDi Bella, Emanuela Esposito, Rosaria Meli & Salvatore Cuzzocrea. (2006) Effects of combination of melatonin and dexamethasone on acute lung injury in a mice model of carrageenan-induced pleurisy. Journal of Pineal Research 41:3, pages 228-237.
Crossref
Crossref
Yasuko Shibata, Naomi Ogura, Keisuke Yamashiro, Shogo Takashiba, Toshirou Kondoh, Keiji Miyazawa, Masaru Matsui & Yoshimitsu Abiko. (2005) Anti-inflammatory effect of linear polarized infrared irradiation on interleukin-1β-induced chemokine production in MH7A rheumatoid synovial cells. Lasers in Medical Science 20:3-4, pages 109-113.
Crossref
Crossref
Ravi Shukla, Vipul Bansal, Minakshi Chaudhary, Atanu Basu, Ramesh R. Bhonde & Murali Sastry. (2005) Biocompatibility of Gold Nanoparticles and Their Endocytotic Fate Inside the Cellular Compartment: A Microscopic Overview. Langmuir 21:23, pages 10644-10654.
Crossref
Crossref
Salvatore Cuzzocrea, Emanuela Mazzon, Rosanna Di Paola, Tiziana Genovese, Carmelo Muià, Achille P. Caputi & Daniela Salvemini. (2005) Effects of combination M40403 and dexamethasone therapy on joint disease in a rat model of collagen-induced arthritis. Arthritis & Rheumatism 52:6, pages 1929-1940.
Crossref
Crossref
Maria Pia Rigobello, Guido Scutari, Rita Boscolo & Alberto Bindoli. (2009) Induction of mitochondrial permeability transition by auranofin, a Gold(I)‐phosphine derivative. British Journal of Pharmacology 136:8, pages 1162-1168.
Crossref
Crossref
M NAGASHIMA, S YOSHINO, H AONO, M TAKAI & M SASANO. (1999) Inhibitory effects of anti-rheumatic drugs on vascular endothelial growth factor in cultured rheumatoid synovial cells. Clinical and Experimental Immunology 116:2, pages 360-365.
Crossref
Crossref
M. Nagashima, K. Wauke, D. Hirano, S. Ishigami, H. Aono, M. Takai, M. Sasano & S. Yoshino. (2000) Effects of combinations of anti‐rheumatic drugs on the production of vascular endothelial growth factor and basic fibroblast growth factor in cultured synoviocytes and patients with rheumatoid arthritis. Rheumatology 39:11, pages 1255-1262.
Crossref
Crossref
Elliot D. Rosenstein & Jacques R. Caldwell. (1999) TRACE ELEMENTS IN THE TREATMENT OF RHEUMATIC CONDITIONS. Rheumatic Disease Clinics of North America 25:4, pages 929-935.
Crossref
Crossref
Kiyoshi Fujisawa, Sadako Imai & Yoshihiko Moro-oka. (1998) Two-Coordinate Gold(I) Aliphatic Thiolate Complex: The Au-S Distance Is Smaller than the Ag-S One. Chemistry Letters 27:2, pages 167-168.
Crossref
Crossref
Simon P. Fricker. (1996) Medicinal chemistry and pharmacology of gold compounds. Transition Metal Chemistry 21:4, pages 377-383.
Crossref
Crossref
Carsten Goebel, Malgorzata Kubicka-Muranyi, Torsten Tonn, José Gonzalez & Ernst Gleichmann. (1995) Phagocytes render chemicals immunogenic: oxidation of gold(I) to the T cell-sensitizing gold(III) metabolite generated by mononuclear phagocytes. Archives of Toxicology 69:7, pages 450-459.
Crossref
Crossref
TERESA K. NEIL, ROBERT A. STOLTZ, SAMUEL JIANG, MICHAL LANIADO-SCHWARTZMAN, MICHAEL W. DUNN, RICHARD D. LEVERE, ATALLAH KAPPAS & NADER G. ABRAHAM. (1995) Modulation of Corneal Heme Oxygenase Expression by Oxidative Stress Agents. Journal of Ocular Pharmacology and Therapeutics 11:3, pages 455-468.
Crossref
Crossref
Irene A. M. Vint, John C. Foreman & Benjamin M. Chain. (2005) The gold anti‐rheumatic drug auranofin governs T cell activation by enhancing oxygen free radical production. European Journal of Immunology 24:9, pages 1961-1965.
Crossref
Crossref
P. E. Prete, J. Zane, M. Krailo & M. Bulanowski. (1994) Randomized trial of switching rheumatoid arthritis patients in remission with injectable gold to auranofin. Clinical Rheumatology 13:1, pages 60-69.
Crossref
Crossref
Michael J. Abrams & Barry A. Murrer. (1993) Metal Compounds in Therapy and Diagnosis. Science 261:5122, pages 725-730.
Crossref
Crossref
S. J. Gadd, M. W. Whitehouse & B. Vernon-Roberts. (1992) Conditional pharmacology: II. Ambivalent effects of aurocyanide, a putative active metabolite of anti-arthritic gold drugs, on human and rat PMN leucocytes. Inflammopharmacology 1:4, pages 305-314.
Crossref
Crossref
P R Colville-Nash & D L Scott. (1992) Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications.. Annals of the Rheumatic Diseases 51:7, pages 919-925.
Crossref
Crossref
E. Gleichmann, M. Kubicka-Muranvi, P. Kind, R. Goldermann, G. Goerz, H. Merk & R. Rau. (1991) Insights into the mechanism of gold action provided by immunotoxicology: biooxidation of gold(I) to gold(III) detected by sensitized T-cells. Rheumatology International 11:4-5, pages 219-220.
Crossref
Crossref
G. G. Graham, G. D. Champion & J. B. Ziegler. (1991) The antirheumatic gold complexes: Considerations of chemical form in studies on their mechanism of action. Inflammopharmacology 1:2, pages 99-102.
Crossref
Crossref
A. L. Parke, C. Ioannides, D. F. V. Lewis & D. V. Parke. (1991) Molecular pathology of drug-disease interactions in chronic autoimmune inflammatory diseases. Inflammopharmacology 1:1, pages 3-36.
Crossref
Crossref